---
title: "ORIENTAL YUHONG today conducted a block trade at a discount, with 4.57 million shares traded and a transaction amount of 51.4582 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256876275.md"
description: "On September 11th, ORIENTAL YUHONG had a block trade of 4.57 million shares, with a transaction amount of 51.4582 million yuan, accounting for 10.75% of the total transaction amount on that day. The transaction price was 11.26 yuan, a discount of 4.98% compared to the market closing price of 11.85 yuan"
datetime: "2025-09-11T08:47:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256876275.md)
  - [en](https://longbridge.com/en/news/256876275.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256876275.md)
generator: "portal-rs"
---

# ORIENTAL YUHONG today conducted a block trade at a discount, with 4.57 million shares traded and a transaction amount of 51.4582 million yuan

On September 11th, ORIENTAL YUHONG had a block trade of 4.57 million shares, with a transaction amount of 51.4582 million yuan, accounting for 10.75% of the total transaction amount that day. The transaction price was 11.26 yuan, a discount of 4.98% compared to the market closing price of 11.85 yuan

### Related Stocks

- [002271.CN](https://longbridge.com/en/quote/002271.CN.md)

## Related News & Research

- [Leave a Nest Capital president makes first appearance at TECH GARAGE Seminar in Malaysia](https://longbridge.com/en/news/297597370.md)
- [Redstone launches EUR 10 million North Karelia Growth Fund II for early-stage startups, Business Joensuu says](https://longbridge.com/en/news/297465528.md)
- [EXCLUSIVE-CIA-backed investor helped top German drones firm break into US](https://longbridge.com/en/news/297464128.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [UVC Partners leads INLEAP Photonics seed round raising about €20 million](https://longbridge.com/en/news/297610044.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**